CD200R1L-AS1

Across TCGA pan-cancer cohorts, CD200R1L-AS1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of CD200R1L-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where CD200R1L-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CD200R1L-AS1 is over-expressed in tumor, although a few such as LUSC and UCEC show the opposite, repressed pattern.

KIRC, LUSC, and UCEC are the cancer types where CD200R1L-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CD200R1L-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	+0.041	.001	7	view →
LUSC	All	II,III,IV	−0.257	.027	3	view →
UCEC	All	All	−0.186	.001	2	view →
THCA	Male	All	+0.025	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

CD200R1L-AS1–KIRC

Open the KIRC breakdown →